Neurofibromatosis type 2 (NF2) Overview Neurofibromatosis type 2 (NF2), also known as NF2-related schwannomatosis, is a rare genetic disorder characterized by noncancerous (benign) tumors, particularly bilateral vestibular schwannomas affecting hearing and balance. Caused by a mutation in the NF2 gene on chromosome 22, it leads to tumors on cranial/spinal nerves (meningiomas, ependymomas). Symptoms typically appear in adolescence or early adulthood, including hearing loss, tinnitus, and balance issues Symptoms Primary Symptoms (Vestibular Schwannomas) Hearing loss: Usually affects both ears and is often the first sign, starting early in life. Tinnitus: A persistent ringing or buzzing sound in the ears. Balance problems: Vertigo and instability, causing difficulty with balance or walking. Other Neurological and Physical Symptoms Facial weakness/numbness: Caused by tumors pressing on facial nerves. Headaches: Frequent headaches. Muscle weakness/numbness: Weakness or numbness in...
Sarcopenia overview Sarcopenia is the gradual loss of muscle mass, strength and physical performance that happens with age. It affects your musculoskeletal system and can make everyday tasks — like climbing stairs or getting out of a chair — harder over time. As your muscles weaken, your risk of falls, fractures and loss of independence goes up. The definition of sarcopenia (pronounced “sar-ko-PEE-nee-uh”) focuses on how muscle loss affects your strength and ability to function. Experts generally define it using one or more key features: Low muscle mass Low muscle strength Low physical performance In some cases, sarcopenia occurs along with a higher body mass index (BMI). This combination, called sarcopenic obesity, can raise your risk of complications more than obesity or sarcopenia alone. In 2016, sarcopenia was recognized as a specific disease with an ICD-10-CM code. This step helped distinguish sarcopenia from other conditions that cause muscle loss and made it a reportable diagnos...